Rabdomiosarcoma embrionario en un paciente pediátrico.

Katiuska Mederos Mollineda.; Yaima Beatriz Tabares Cruz; Gabriela De Jesús Vásquez Espinosa; Kathiusca Paola Echevarría Caicedo

doi:10.46377/dilemas.v35i1.2282

Katiuska Mederos Mollineda. Universidad Estatal de Milagro, Guayaquil - Ecuador.
Yaima Beatriz Tabares Cruz Universidad Estatal de Milagro, Guayaquil - Ecuador.
Gabriela De Jesús Vásquez Espinosa Universidad Estatal de Milagro, Guayaquil - Ecuador.
Kathiusca Paola Echevarría Caicedo Universidad Estatal de Milagro, Guayaquil, Ecuador.

DOI: https://doi.org/10.46377/dilemas.v35i1.2282

Palabras clave: Rabdomiosarcoma, embrionario, células musculares, tejido conjuntivo

Resumen

Se describe el caso clínico de un paciente de 4 años de edad, masculino que sufrió traumatismo ocular debido a un golpe con el timón de una moto en el ojo derecho, presentando dolor al pasar los días y protrusión leve del ojo, recibiendo tratamiento sintomático con evolución desfavorable por lo que se realizan exámenes de laboratorios y estudios radiológicos, por los hallazgos en la resonancia magnética se decide toma de muestra para biopsia, iniciando tratamiento urgente con quimioterapia siendo el diagnóstico un rabdomiosarcoma embrionario el cual presenta buen pronóstico en un 70% de los casos con tratamiento oportuno y específico.

Citas

Arndt C.A, Donaldson SS, Anderson JR, et al. (2001). What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 91 (12): 2454-68.

Bisogno G, Compostella A, Ferrari A, et al. (2012). Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee. Cancer 118 (3): 821-7.

Casanova M, Meazza C, Favini F, et al. (2009). Rhabdomyosarcoma of theextremities: a focusontumorsarising in thehand and foot. Pediatr Hematol Oncol 26 (5): 321-31, Jul-Aug

Crist W, Gehan EA, Ragab AH, et al. (1995): The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13 (3): 610-30

Diller L, Sexsmith E, Gottlieb A, et al. (1995) Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 95 (4): 1606-11.

Feinberg, A. P., Rainier, S., & DeBaun, M. R. (1995). Genomic imprinting, DNA methylation, and cancer. Monographs-Journal of the National Cancer Institute, (17), 21-26.

Hartley AL, Birch JM, Blair V, et al. (1993). Patterns of cancer in thefamilies of childrenwithsofttissue sarcoma. Cancer august 1, volume 72, No. 3. https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/1097-0142%2819930801%2972%3A3%3C923%3A%3AAID-CNCR2820720343%3E3.0.CO%3B2-Y

Healthwise, (2019). Tratamiento del rabdomiosarcoma infantil (PDQ®) : Tratamiento - información para profesionales de salud [NCI]: Obtenido de NothShore University HealthSystem: https://www.northshore.org/healthresources/encyclopedia/encyclopedia.aspx?DocumentHwid=ncicdr0000062792&Lang=es-us

Joshi D, Anderson JR, Paidas C, et al. (2004). Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 42 (1): 64-73.

Mafee MF. Órbita (2004): embriología, anatomía y patología. En: Som PM, Curtin HD, eds. Radiología de cabeza y cuello. 4º ed. Madrid: Elsevier; 529-654.

Malempati S, Rodeberg DA, Donaldson SS, et al. (2011). Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group. Cancer 117 (15): 3493-501.

Ognjanovic S, Carozza SE, Chow EJ, et al. (2010). Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer 102 (1): 227-31.

Ognjanovic S, Linabery AM, Charbonneau B, et al. (2009): Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer 115 (18): 4218-26.

Parham DM, Ellison DA (2006). Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 130 (10): 1454-65, 2006.

Réguerre Y, Martelli H, Rey A, et al. (2012) Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee. Eur J Cancer 48 (13): 2020-7.

Sung L, Anderson JR, Donaldson SS, et al. (2004). Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Eur J Cancer 40 (12): 1878-85.

Trahair T, Andrews L, Cohn RJ. (2007). Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma. Pediatr Blood Cancer 48 (3): 345-8.

Van Gaal JC, Van Der Graaf WT, Rikhof B, et al. (2012) The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study. Anticancer Res 32 (10): 4485-97.

Weigel BJ, Breitfeld PP, Hawkins D, et al. (2001). Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol 23 (5): 272-6, Jun-Jul.